The North America peripheral vascular devices market has shown a consistent growth trend from 2020 and is projected to continue expanding through 2035. In 2025, the market is estimated to reach USD 7,200 million, with increasing procedural volumes and rapid adoption of advanced technologies across both public and private healthcare settings. This growth is fueled by aging demographics, higher disease incidence, and continuous investment in R&D by market leaders. The revenue trajectory signals both short-term acceleration from new device launches and long-term opportunities driven by preventive healthcare initiatives and value-based care models.
Read More - https://bussinessinsights.com/research-report/north-america-peripheral-vascular-devices-market
Peripheral artery disease (PAD) is the leading application segment, reflecting the high disease burden and growing geriatric population across North America. Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, also represents a significant portion, underscoring the need for effective interventional therapies. The treatment of aneurysms and chronic venous insufficiency further propels market adoption as device options diversify. Enhanced awareness, progressive clinical guidelines, and the migration toward early diagnosis and intervention are cementing the relevance of these applications, sustaining robust market expansion in healthcare institutions.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-peripheral-vascular-devices-market
Who are the key players in North America Peripheral Vascular Devices Market industry?
The key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton, Dickinson and Company (BD), and Cook Medical. These companies offer a broad range of innovative devices, robust R&D capabilities, and extensive distribution networks, solidifying their leading positions within the competitive North American peripheral vascular devices market.
What is the North America Peripheral Vascular Devices Market growth?
The North America Peripheral Vascular Devices Market is experiencing notable growth, with an estimated CAGR of over 6% during 2022-2027. Factors such as product launches by major companies like Boston Scientific and the rising prevalence of peripheral artery diseases are fueling the market expansion across the region.
Which segment accounted for the largest North America Peripheral Vascular Devices Market share?
Angioplasty balloons accounted for the largest share in the North America Peripheral Vascular Devices Market. These devices are widely used for minimally invasive treatment of vascular blockages, favoring their adoption due to high procedural success rates and technological advancements in balloon design for improved patient outcomes.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com